Skip to main content

Table 3 Laboratory criteria of the studied VA-ECMO-treated patients

From: Acute vascular complications of femoral veno-arterial ECMO: a single-centre retrospective study

Studied criteria All patients Limb ischemia group No limb ischemia group P value
Haemoglobin (g/L) 111 (88–166) 105 (88–153) 111 (88–166) 0.9
Platelet count (109/L) 181 (38–447) 160 (112–329) 215 (38–447) 0.32
INR 1.6 (1.1–3.6) 1.9 (1.4–3.2) 1.4 (1.1–3.6) 0.004
aPTT (seconds) 42.2 (31.3–150) 48.2 (33.9–150) 41.3 (31.3–74.3) 0.06
PTT ratio 1.2 (0.9–4.4) 1.4 (1–4.4) 1.2 (0.9–2.2) 0.13
Fibrinogen (g/L) 3.16 (0.76–6.87) 2.38 (0.76–6.87) 3.39 (1.37–6.06) 0.28
Antithrombin III 58 (27–88) 69 (27–88) 55.5 (42–73) 0.002
Serum creatinine (μmol/L) 91 (9.5–320) 115 (48–298) 81 (9.5–320) 0.01
Serum albumin (g/L) 32.2 (18.3–44.1) 37.4 (22.2–44.1) 31.1 (18.3–44.1) 0.04
Serum bilirubin (μmol/L) 28.6 (5.8–389) 58.7 (5.8–79.7) 53.5 (7.5–389) 0.71
PH 7.17 (6.9 –7.34) 7.12 (6.9 – 7.34) 7.20 (6.9 – 7.34) 0.69
Base excess − 9.3 (− 18.6 to – 4.8) − 11.2 (− 18.6 to − 5.3) − 8.25 (− 16.4 to – 4.8) 0.25
Blood lactate (mmol/L) 4.8 (2.4–12.4) 4.8 (3.6–12.4) 5.2 (2.4–10.7) 0.91
Peak blood lactate 13.2 (6.7–20) 13.2 (7.4–20) 11.2 (6.7–20) 0.08
Blood lactate at 24 h 3.1 (1.1–20) 3.1 (1.1–14.3) 2.9 (1.1–20) 0.27
  1. Data are presented as median (IQR)